Watch: Why should pharmaceutical companies choose cross-coupling catalysis?

Powerful, simple and efficient, cross-coupling catalysis provides pharmaceutical development teams with an efficient way to generate carbon-carbon bonds. 

Watch as three cross-coupling catalysis experts, Philipp Oczipka, Head of Technical Sales and Business Development of Homogeneous Catalysts at Umicore PMC, Nilay Hazari, Professor at Yale University, and Viktoria Gessner, Head of Inorganic Chemistry at Ruhr University Bochum, discuss this technology and its role in enabling pharmaceutical processes.

This clip is taken from the Umicore PMC roundtable on cross-coupling catalysis, where academic and  industrial leaders shared their perspectives on the growing use of this impressive technology.

Roundtable with Philipp Oczipka, Nilay Hazari and Viktoria Gessner - Part 5

Produced in collaboration with The Medicine Maker, discover insights into how cross-coupling catalysis has changed in recent years in both the chemical and pharmaceutical industries from three industry experts.

Watch the full roundtable via The Medicine Maker here: